Torres, A;
Niederman, M. S;
Chastre, J;
Ewig, S;
Fernandez-Vandellos, P;
Hanberger, H;
Kollef, M;
Li Bassi, G;
Luna, C. M;
Martin-Loeches, I;
Paiva, J. A;
Read, R. C;
Rigau, D;
Timsit, J. F;
Welte, T;
Wunderink, R.
The most recent European guidelines and task force reports on hospital-acquired pneumonia (HAP) and ventilator-associated pneumonia (VAP) were published almost 10 years ago. Since then, further randomised clinical trials of HAP and VAP have been conducted and new information has become available. Studi...
Cho, Young-Jae;
Cho, Young-Jae;
Moon, Jae Young;
Shin, Ein-Soon;
Kim, Je Hyeong;
Jung, Hoon;
Park, So Young;
Kim, Ho Cheol;
Sim, Yun Su;
Rhee, Chin Kook;
Lim, Jaemin;
Lee, Seok Jeong;
Lee, Won Yeon;
Lee, Hyun Jeong;
Kwak, Sang Hyun;
Kang, Eun Kyeong;
Chung, Kyung Soo;
Choi, Won-Il.
Since the first description of acute respiratory distress syndrome (ARDS) as a series of 12 patients in 1967 by Ashbaugh
et al.1
, it still remains a major public health problem that incurs
high health care costs and causes major mortality in the intensive care unit (ICU) despite improvements in outcomes...
Community-acquired pneumonia is diagnosed by clinical features (e.g., cough, fever, pleuritic chest pain) and by lung
imaging, usually an infiltrate seen on chest radiography. Initial evaluation should determine the need for hospitalization versus outpatient management using validated mortality or severi...
Neumonía/diagnóstico por imagen,
Neumonía/terapia,
Enfermedades Respiratorias/diagnóstico,
Atención Ambulatoria/organización & administración,
Cultivo de Sangre/instrumentación,
Macrólidos/uso terapéutico,
Doxiciclina/uso terapéutico,
Antibacterianos/uso terapéutico,
Fluoroquinolonas/uso terapéutico,
Unidades de Cuidados Intensivos,
Neumonía Asociada a la Atención Médica/prevención & control
